These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
450 related articles for article (PubMed ID: 30831390)
1. Anticancer activity and mechanism of bis-pyrimidine based dimetallic Ru(II)(η Bhatti MZ; Ali A; Duong HQ; Chen J; Rahman FU J Inorg Biochem; 2019 May; 194():52-64. PubMed ID: 30831390 [TBL] [Abstract][Full Text] [Related]
2. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
4. Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells. Guo L; Lv G; Qiu L; Yang H; Zhang L; Yu H; Zou M; Lin J Eur J Pharmacol; 2016 Sep; 786():60-71. PubMed ID: 27262377 [TBL] [Abstract][Full Text] [Related]
6. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand. Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099 [TBL] [Abstract][Full Text] [Related]
9. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes. Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601 [TBL] [Abstract][Full Text] [Related]
10. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes. Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042 [TBL] [Abstract][Full Text] [Related]
11. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, chemical characterization, PARP inhibition, DNA binding and cellular uptake of novel ruthenium(II)-arene complexes bearing benzamide derivatives in human breast cancer cells. Pavlović M; Tadić A; Gligorijević N; Poljarević J; Petrović T; Dojčinović B; Savić A; Radulović S; Grgurić-Šipka S; Aranđelović S J Inorg Biochem; 2020 Sep; 210():111155. PubMed ID: 32768729 [TBL] [Abstract][Full Text] [Related]
14. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study. Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417 [TBL] [Abstract][Full Text] [Related]